Trial record 5 of 10 for:    aastrom

Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia (RESTORE-CLI)

This study has been completed.
Information provided by (Responsible Party):
Aastrom Biosciences Identifier:
First received: April 30, 2007
Last updated: October 1, 2012
Last verified: October 2012